Global pharmaceutical sales vary significantly across major therapeutic categories, with oncology leading the market by a massive margin.
According to data from Statista Market Insights, cancer drugs generate the highest pharmaceutical revenue worldwide, reaching an estimated 232.5 billion US dollars.
Anti-diabetics form the second-largest category at 91.8 billion dollars, followed by immunosuppressants at 72.0 billion dollars.
Vaccines also generate substantial global sales, accounting for 64.6 billion dollars, while antivirals bring in 58.2 billion dollars.
Rounding out the primary therapeutic sectors shown are anti-rheumatics, which total 42.0 billion dollars in estimated sales, and anti-coagulants at 36.8 billion dollars.
Altogether, these figures highlight how specialised treatments, particularly cancer therapies and chronic condition management drugs, drive the vast majority of global revenues within the modern pharmaceutical industry.
